When I reflect on the characteristics of successful advanced biotechnology companies that have achieved commercial scale, and the longer list of companies that haven’t, the difference between success ...
The global biotechnology market was valued at more than $1.5 trillion in 2023. By 2030, that value is expected to balloon to nearly $4 trillion, according to Grand View Research. To help explain that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results